GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 113.55 billion as of April 28, 2026. Its market cap has decreased by -21.67% in one year.

Market Cap

113.55B

Enterprise Value

105.58B

Revenue

65.90B

Ranking

n/a

PE Ratio

11.33

Stock Price

356.56

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 113.55B, an increase of 2,911.33%. That is a compound annual growth rate of 11.37%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	113.55B	-8.52%
Dec 31, 2025	124.13B	-1.80%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	90.09B
The Searle Company	55.22B
AGP Limited	52.32B
Highnoon Laboratories	50.63B
Citi Pharma	18.28B
Ferozsons Laboratories	17.84B
Macter International	13.49B
Otsuka Pakistan	3.66B

Market Cap Rankings